Alaptide
Alternative Names: VUFB 15754Latest Information Update: 28 Sep 2001
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Developer IVAX Pharmaceuticals s.r.o.; Nonindustrial source
- Class Antiulcers; Nootropics
- Mechanism of Action Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease; Duodenal ulcer; Parkinson's disease; Skin disorders
Most Recent Events
- 28 Sep 2001 No-Development-Reported for Alzheimer's disease in Czech Republic (Unknown route)
- 28 Sep 2001 No-Development-Reported for Duodenal ulcer in Czech Republic (Unknown route)
- 28 Sep 2001 No-Development-Reported for Parkinson's disease in Czech Republic (Unknown route)